Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of CYP1A2 on the Acute Effect of Caffeine Intake on Resistance Exercise

NCT06610110 is registered in ClinicalTrials.gov with Alberto Pérez-López as lead sponsor.

NCT NCT06610110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06610110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of CYP1A2 on the Acute Effect of Caffeine Intake on Resistance Exercise
Lead sponsor
Alberto Pérez-López
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2024
Completion date
July 30, 2025
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

caffeine and resistance exercise, cyp1a2 polymorphism